Function and Histopathology of a Cell Adhesion Molecule TSLC1 in Cancer

CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease

(2010) Kequan Chen et al.   INTERNATIONAL JOURNAL OF CANCER

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bβ and TSLC1 in neuroblastoma

(2010) H Ochiai et al.   ONCOGENE

Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours

(2008) Olaf J.C. Hellwinkel et al.   BJU INTERNATIONAL

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

(2008) Annie Hurtubise et al.   Cancer Cell International

Expression ofTSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation

(2008) Kiyohiro Ando et al.   INTERNATIONAL JOURNAL OF CANCER

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC

(2008) RM Overmeer et al.   JOURNAL OF PATHOLOGY

Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas

(2008) Seung-Mo Hong et al.   MODERN PATHOLOGY